Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-2.92%
-2.08%
+9.79%
-19.01%
-3.34%
OWL
Blue Owl Capital Inc
$18.68
Chart
$16.51 (+13.14%)
$19.42 (-3.81%)
$26.03 (-28.24%)
$17.11 (+9.18%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-2.92%
-2.08%
+9.79%
-19.01%
-3.34%
OWL
Blue Owl Capital Inc
Current Price
$18.68
Login to view Blue Owl Capital Inc (OWL) recommendation from the last 90 days from financial news and social media.
Chart
$16.51 (+13.14%)
$19.42 (-3.81%)
$26.03 (-28.24%)
$17.11 (+9.18%)
OWL Latest Headlines
Blue Owl Chirisa and PowerHouse unveil next phase of $5B data center JV.
Wed May 28, 2025
Blue Owl Chirisa Technology Parks and PowerHouse Data Centers Announce Next Phase of $5 Billion Joint Venture Development Partnership. CHESTERFIELD Va. May 27 2025 /PRNewswire/ -- Blue Owl Capital managed funds (Blue Owl) Chirisa Technology Parks (CTP) and PowerHouse Data Centers (PowerHouse) today announced the closing of a $750 million transaction in their landmark joint venture development partnership. The...
Wed May 28, 2025
ITM Secures Up to $262.5m in Non-dilutive Debt Financing with Blue Owl Managed Funds. Debt capital to support commercial readiness and potential United States launch of n.c.a. 177Lu-edotreotide (ITM-11) following positive Phase 3 resultsFlexible funding structure enables continued advancement of ITM'.s targeted radiopharmaceutical pipeline and leading radioisotope manufacturing business a leading radiopharmaceutical biotech company today announced a debt financing agreement for up to USD 262
Tue May 27, 2025
ITM Secures Up to $262.5m in Non-dilutive Debt Financing with Blue Owl Managed Funds. Debt capital to support commercial readiness and potential United States launch of n.c.a. 177Lu-edotreotide (ITM-11) following positive Phase 3 resultsFlexible funding structure enables continued advancement of ITM'.s targeted radiopharmaceutical pipeline and leading radioisotope manufacturing business a leading radiopharmaceutical biotech company today announced a debt financing agreement for up to USD 262
Tue May 27, 2025
ITM Secures Up to $262.5m in Non-dilutive Debt Financing with Blue Owl Managed Funds. Debt capital to support commercial readiness and potential United States launch of n.c.a. 177Lu-edotreotide (ITM-11) following positive Phase 3 resultsFlexible funding structure enables continued advancement of ITM'.s targeted radiopharmaceutical pipeline and leading radioisotope manufacturing business a leading radiopharmaceutical biotech company today announced a debt financing agreement for up to USD 262
Tue May 27, 2025
Crusoe Blue Owl Capital Primary Digital Infrastructure enter second phase of $15B joint venture.
Wed May 21, 2025
10 Analysts Have This To Say About Blue Owl Capital. Analysts'. ratings for Blue Owl Capital (NYSE:) over the last quarter vary from ish to bearish as provided by 10 analysts.The table below summarizes their recent ratings showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.2530001000101001310001100The 12-month price targets analyzed by analysts offer insights with an average target of $22.8 a high estimate of $29.00 and a low estimate of $19
Tue May 20, 2025
Blue Owl Capital: Discount To NAV High Yield Post-Merger Synergies Attractive.
Tue May 20, 2025
Blue Owl Capital: Discount To NAV High Yield Post-Merger Synergies Attractive.
Tue May 20, 2025
Expert Outlook: Blue Owl Capital Through The Eyes Of 7 Analysts. Across the recent three months 7 analysts have shared their insights on Blue Owl Capital (NYSE:) expressing a variety of opinions spanning from ish to bearish.The table below offers a condensed view of their recent ratings showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.1330001000011001020001000The 12-month price targets analyzed by analysts offer insights with an average target o
Thu May 15, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
